Synonyms: example 57 [US11466000B2]
Compound class:
Synthetic organic
Comment: Enozertinib is the INN for an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor that is claimed in Voronoi Inc. patent US11466000B2 (as example 57) [1]. Voronoi have two EGFR inhibitors listed on their development pipeline page (VRN07 and VRN11), but without a name to structure declaration we cannot be sure which one wil be aligned with this INN.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
N-[2-[4-(4-cyclopropylpiperazin-1-yl)piperidin-1-yl]-5-[[6-[(3R)-3-(3,5-difluorophenyl)-1,2-oxazolidin-2-yl]pyrimidin-4-yl]amino]-4-methoxyphenyl]prop-2-enamide |
International Nonproprietary Names ![]() |
|
INN number | INN |
13344 | enozertinib |
Synonyms ![]() |
example 57 [US11466000B2] |
Database Links ![]() |
|
CAS Registry No. | 2489185-38-6 (source: WHO INN record) |
GtoPdb PubChem SID | 507750377 |
PubChem CID | 155696192 |
Search Google for chemical match using the InChIKey | NNDXFTMFJKUUQA-SSEXGKCCSA-N |
Search Google for chemicals with the same backbone | NNDXFTMFJKUUQA |
Search PubMed clinical trials | enozertinib |
Search PubMed titles | enozertinib |
Search PubMed titles/abstracts | enozertinib |
UniChem Compound Search for chemical match using the InChIKey | NNDXFTMFJKUUQA-SSEXGKCCSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | NNDXFTMFJKUUQA-SSEXGKCCSA-N |